Cyclezyme AB Logo

Cyclezyme AB

Develops enzymatic solutions for recycling plastic waste into new raw materials.

CYCLE | SPGR

Overview

Corporate Details

ISIN(s):
SE0020975852
LEI:
64882FL345VE0KT42O30
Country:
Sweden
Address:
Scheelevägen 22, 223 63 Lund
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Cyclezyme AB is a Swedish biotechnology company specializing in the research and development of enzymatic solutions for plastic recycling. The company's core focus is its enzymatic platform, which creates processes to break down plastic waste, particularly Polyethylene Terephthalate (PET). This technology aims to enable a circular economy by transforming used plastics into raw materials for new products, thereby reducing climate impact and the need for virgin plastic production. Cyclezyme's business model is centered on offering enzymes and green biochemical processes for the efficient recycling of various plastic materials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cyclezyme AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cyclezyme AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cyclezyme AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France
POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan
2449
Predictive Oncology Inc. Logo
AI platform uses a vast tumor biobank to predict drug response and accelerate oncology discovery.
United States of America
POAI
Prime Medicine, Inc. Logo
Developing 'search and replace' gene editing therapies to treat genetic disorders.
United States of America
PRME
ProPhase Labs, Inc. Logo
Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.
United States of America
PRPH
PROTHENA CORP PUBLIC LTD CO Logo
Advancing antibody-based therapies for neurodegenerative and rare amyloid diseases.
United States of America
PRTA
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America
950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America
PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel
PPBT
Qualigen Therapeutics, Inc. Logo
A clinical-stage company developing innovative treatments for rare cancers in adults and children.
United States of America
QLGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.